Reducing Diagnostic Error to Improve Patient Safety in COPD and Asthma (REDEFINE Study)

Completed · Phase 3

Conditions studied: COPD Asthma

In brief

The purpose of this study is to evaluate the use of spirometry in identifying Diagnostic Error in COPD and Asthma patients.

Key facts

Study ID

NCT03137303

Run by

University of Illinois at Chicago

People needed

402

Starts

2017-07-01

Expected to finish

2019-09-30

Last updated by the study team

2024-02-26

Who can join

Age: 40 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• 1.Age ≥40 years of age
• 2. Use of a maintenance respiratory medication and one of the following in the past year:
• 3. Diagnosis of asthma and/or COPD
• 4. No spirometry test performed in the past 3 years
• 5. Past or current smoker or is exposed to tobacco

You may not qualify if…

• Unable to perform adequate spirometry
• Non-English speaking
• Pregnancy
• Plans to move from the Chicago Area within the next year
• Seen by pulmonary specialist in the past 3 years
• Any terminal illness with a life expectancy of <6 months
• Life threatening (e.g. intensive care admission and/or use of mechanical ventilation) respiratory failure event in the past year.

Where it is running

• CCHHS — Chicago, Illinois, United States
• UI Health — Chicago, Illinois, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.